Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
about
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repairNeuron-Glia Interactions in Neural Plasticity: Contributions of Neural Extracellular Matrix and Perineuronal NetsBiomaterial Approaches to Enhancing Neurorestoration after Spinal Cord Injury: Strategies for Overcoming Inherent Biological ObstaclesVersican and the regulation of cell phenotype in diseaseUnderstanding the NG2 Glial Scar after Spinal Cord InjuryAdult oligodendrocyte progenitor cells - Multifaceted regulators of the CNS in health and disease.Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limitedADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury.Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?Chondroitinase ABC enhances pericontusion axonal sprouting but does not confer robust improvements in behavioral recoveryMolecular profiles of pyramidal neurons in the superior temporal cortex in schizophreniaEntrapment via synaptic-like connections between NG2 proteoglycan+ cells and dystrophic axons in the lesion plays a role in regeneration failure after spinal cord injury.Hyaluronan as an immune regulator in human diseases.NG2 cells are uniformly distributed and NG2 is not required for barrel formation in the somatosensory cortex.Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage.Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study.Smad proteins differentially regulate transforming growth factor-β-mediated induction of chondroitin sulfate proteoglycansNeuronally produced versican V2 renders C-fiber nociceptors IB4 -positiveSensory axon regeneration: rebuilding functional connections in the spinal cord.The yellow fluorescent protein (YFP-H) mouse reveals neuroprotection as a novel mechanism underlying chondroitinase ABC-mediated repair after spinal cord injury.Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera.Expression and activation of ephexin is altered after spinal cord injury.Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative ImmunohistochemistryAxonal mRNA in uninjured and regenerating cortical mammalian axons.Proteoglycans and their roles in brain cancer.Roles of chondroitin sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after traumatic injury of the mouse brain.A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries.Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Is Constitutively Expressed in Adult Central Nervous System (CNS) and Associated with Astrocyte-mediated Glial Scar Formation following Spinal Cord Injury.Chondroitinase ABC-mediated plasticity of spinal sensory function.Long-term characterization of axon regeneration and matrix changes using multiple channel bridges for spinal cord regeneration.Astrocytic and vascular remodeling in the injured adult rat spinal cord after chondroitinase ABC treatment.Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damageAggrecan is expressed by embryonic brain glia and regulates astrocyte development.Gene delivery to overcome astrocyte inhibition of axonal growth: an in vitro model of the glial scar.Combined chondroitinase and KLF7 expression reduce net retraction of sensory and CST axons from sites of spinal injury.Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowthPhosphacan and receptor protein tyrosine phosphatase β expression mediates deafferentation-induced synaptogenesis.Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex.ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.
P2860
Q21284516-FE8BCAE2-17AD-4EC2-B7BE-2E353B7D1380Q26765730-E43282F8-FA14-4160-A1E1-DD86CF5448C6Q26780494-3D8A4C4E-C998-4715-8D56-E4F72E1B60B8Q27690926-E41510BA-1DB1-4D5E-A7B6-5A22338F370CQ28078778-5C0F4BDE-9A36-435C-B89D-CE4C472A99B8Q30277699-65216B77-A776-4F81-A832-19C8DB0B0897Q33649452-FD81CEC8-24DE-4093-8670-EB48A218E8C4Q33914563-95588192-EB03-40F9-9AD0-BF3384037421Q34285595-8AD2B032-D6F7-45D8-8A7D-7D36F03B48D0Q34296859-306954D6-DA23-437D-9EC7-FD26C82F69EDQ34336202-3D2FD398-6E0D-48B4-94B2-25F4BE41ACBEQ34614586-51C6B38E-630F-4452-B828-6CC97C38DA16Q34636380-878DF6FE-97E7-431C-B720-73D591EFD150Q34745644-1767821D-71FB-4836-B162-000C099BD006Q35196642-C58DBC42-E374-4C6D-9FAA-6F474ACFE5FEQ35350535-71F667AA-D983-4739-83F1-2E6F64059D3FQ35401997-286A27F3-85D0-4BE1-98D7-85FAF861D6EDQ35756281-202C3BCF-C04E-4E6D-88FE-77B828DE21C2Q35803072-5B9121F4-9C23-418C-8727-56D55D74D0BBQ35923626-DF5E4C43-E277-4B7C-9E65-37411F79AE24Q36383629-A89A849D-3756-4164-B54C-945D42AE0F53Q36445643-C2AE7E9E-9085-4F2E-8443-542F169DAECFQ36774513-3C9C306D-6B42-49AA-9171-49007DD2D329Q36784476-F6A79C05-EF94-4346-9288-D14B17226A0CQ36816444-9B563C7E-789D-44DE-8D8C-8349DA51B8B2Q36968383-24FAA36E-173B-4A6F-8C1F-3F0263A06C96Q37060955-3CDEE297-DFB1-4DEE-85C5-40A0C9902C38Q37249700-C419F094-D7AF-4E74-BF90-6C7D8A1666D0Q37260670-70E1D50F-2A8E-4A49-B165-EDB94C764504Q37352467-30FCFEAD-8A7F-490C-8F38-A899B0CCD95CQ37610624-D178F476-286C-47E0-B750-F5E34F77A42FQ37718952-1AB414EA-B241-469F-8414-526D8B15B2D8Q38246263-368BFA23-206D-4A29-A0DB-753AF60EDA3AQ38781106-6CA98AA4-6BA9-4784-A6D8-0CA5DA7B16CDQ39261846-A8172BA6-99AE-4F39-9791-883460A0E690Q40419695-3B07CC29-F41F-425E-BA3B-DE16FE975110Q40831376-E3309678-36B5-403B-9F7B-B5D8E4AA87CAQ41226571-89BC68CF-6675-4D9C-8CAD-59D9A80243EEQ41448649-06C7206E-CF99-4CF2-BEEB-ADDFA066B8FBQ41810073-EE3629B4-A637-454B-BDA1-F8610E50A3EB
P2860
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
description
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im März 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/03/15)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/03/15)
@nl
наукова стаття, опублікована в березні 2002
@uk
مقالة علمية (نشرت في 15-3-2002)
@ar
name
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@ast
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@en
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@nl
type
label
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@ast
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@en
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@nl
prefLabel
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@ast
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@en
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@nl
P2093
P3181
P1476
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
@en
P2093
James W Fawcett
Kathryn H Adcock
Morven C Shearer
Penka Pesheva
Richard A Asher
P304
P3181
P356
10.1523/JNEUROSCI.22-06-02225.2002
P407
P577
2002-03-01T00:00:00Z